Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas

Sci Rep. 2023 Aug 1;13(1):12450. doi: 10.1038/s41598-023-39545-0.
No abstract available

Publication types

  • Published Erratum